Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

295.91
Delayed Data
As of Mar 30
 +2.00 / +0.68%
Today’s Change
128.50
Today|||52-Week Range
349.08
+89.69%
Year-to-Date

Today’s Trading

Previous close293.91
Today’s open300.99
Day’s range-- - --
Volume603,056
Average volume (3 months)641,805
Market cap$6.7B
Dividend yield--
Data as of 03/30/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+36.53%
Earnings growth (next 5 years)-159.92%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book27.26

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.22+1.52%
PBYIPuma Biotechnology I...+23.76+11.00%
TAROTaro Pharmaceutical ...+0.25+0.17%
IDXXIDEXX Laboratories I...+2.94+1.92%
Data as of 03/30/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$1.77
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account